Organothiophosphorus Compounds
This graph shows the total number of publications written about "Organothiophosphorus Compounds" by people in the URMC Research Network by year, and whether "Organothiophosphorus Compounds" was a major or minor topic of these publication.
Below are the most recent publications written about "Organothiophosphorus Compounds" by people in Profiles.
-
Shuttleworth TJ. Receptor-activated calcium entry in exocrine cells does not occur via agonist-sensitive intracellular pools. Biochem J. 1990 Mar 15; 266(3):719-26.
-
Schor NF. Mechanisms of synergistic toxicity of the radioprotective agent, WR2721, and 6-hydroxydopamine. Biochem Pharmacol. 1988 May 1; 37(9):1751-62.
-
Schor NF. Depletion of glutathione by the radioprotective agent S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR2721). Biochem Pharmacol. 1988 Feb 1; 37(3):562-3.
-
Tabachnik Schor NF. Adjunctive use of ethiofos (WR-2721) with free radical-generating chemotherapeutic agents in mice: new caveats for therapy. Cancer Res. 1987 Oct 15; 47(20):5411-4.
-
Constine LS, Rubin P, Gregory P. The differential protection by WR2721 of skin versus growing cartilage following irradiation in weanling rats. Radiat Res. 1987 Apr; 110(1):61-71.
-
Constine LS, Zagars G, Rubin P, Kligerman M. Protection by WR-2721 of human bone marrow function following irradiation. Int J Radiat Oncol Biol Phys. 1986 Aug; 12(8):1505-8.
-
Tabachnik NF, Blackburn P, Peterson CM, Cerami A. Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721. J Pharmacol Exp Ther. 1982 Feb; 220(2):243-6.
-
Tabachnik NF, Peterson CM, Cerami A. Studies on the reduction of sputum viscosity in cystic fibrosis using an orally absorbed protected thiol. J Pharmacol Exp Ther. 1980 Aug; 214(2):246-9.
